Schistosomiasis project gets $1.15M boost from Gates Foundation

08/26/2013 | Pharmaceutical Business Review Online

An international public-private partnership that aims to develop a pediatric treatment for schistosomiasis, or bilharzia, received a $1.15 million grant from the Bill & Melinda Gates Foundation. Members of the consortium include Astellas Pharma, Merck KGaA and the Swiss Tropical and Public Health Institute.

View Full Article in:

Pharmaceutical Business Review Online

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
Health Alliance Plan of Michigan
Southfield, MI
Senior Vice-President Managed Care Mid-Atlantic Region
Mercy Health System
Conshohocken, PA
Associate Chief Financial Officer
Commonwealth Care Alliance
Boston, MA
Assistant General Counsel, Regulatorya
Cardinal Health
Waukegan, IL
Chief Operating Officer
Health Plan of San Joaquin
French Camp , CA